Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ding Q et al. - The results suggest that the polymorphism in XPC Lys939Gln may modulate superficial bladder cancer risk, and these effects may preferentially affect current smokers. The data also support the possibility of an increased risk for superficial bladder cancer in individuals with a higher number of genetic variations in DNA repair and metabolic enzyme genes.

Related Articles

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
BMC Cancer, 11/13/09    Relevance Score: 70%

Evidence-based Principles of Bladder Cancer and Diet
Urology, 10/21/09    Relevance Score: 70%

Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09    Relevance Score: 70%

Biomarkers in bladder cancer
BJU International, 10/01/09    Relevance Score: 70%

Diagnosis and Treatment of Bladder Cancer
American Family Physician, 10/01/09    Relevance Score: 70%

Today in Hematology/Oncology...keeping you current

The current role of renal biopsy in the management of localized renal tumors
Indian Journal of Urology, 12/09/09

Current status of ablative therapies for renal tumors
Indian Journal of Urology, 12/09/09

Update on novel agents in renal cell carcinoma
Expert Review of Anticancer Therapy, 12/08/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address